.

Deeper Knowledge, Faster

  • Anticipate your formulary budget
  • Analyze global market entry opportunities
  • Drug patents and clinical trials in dozens of countries

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Covington
Citi
Argus Health
Teva
Cantor Fitzgerald
Federal Trade Commission
AstraZeneca
McKinsey
Farmers Insurance
Fish and Richardson

Generated: June 23, 2017

DrugPatentWatch Database Preview

Deferoxamine mesylate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for deferoxamine mesylate and what is the scope of deferoxamine mesylate patent protection?

Deferoxamine mesylate
is the generic ingredient in two branded drugs marketed by Watson Labs, Fresenius Kabi Usa, Hospira, Novartis, and West-ward Pharms Int, and is included in five NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are seven drug master file entries for deferoxamine mesylate. Three suppliers are listed for this compound.

Summary for Generic Name: deferoxamine mesylate

Tradenames:2
Patents:1
Applicants:5
NDAs:5
Drug Master File Entries: see list7
Suppliers / Packagers: see list3
Bulk Api Vendors: see list60
Clinical Trials: see list549
Patent Applications: see list4,572
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:deferoxamine mesylate at DailyMed

Pharmacology for Ingredient: deferoxamine mesylate

Drug ClassIron Chelator
Mechanism of ActionIron Chelating Activity
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi Usa
DEFEROXAMINE MESYLATE
deferoxamine mesylate
INJECTABLE;INJECTION078718-001Sep 15, 2009APRXNoNo► Subscribe► Subscribe
Watson Labs
DEFEROXAMINE MESYLATE
deferoxamine mesylate
INJECTABLE;INJECTION076806-002Mar 31, 2006DISCNNoNo► Subscribe► Subscribe
Hospira
DEFEROXAMINE MESYLATE
deferoxamine mesylate
INJECTABLE;INJECTION076019-001Mar 17, 2004APRXNoNo► Subscribe► Subscribe
West-ward Pharms Int
DEFEROXAMINE MESYLATE
deferoxamine mesylate
INJECTABLE;INJECTION078086-001May 30, 2007APRXNoNo► Subscribe► Subscribe
Fresenius Kabi Usa
DEFEROXAMINE MESYLATE
deferoxamine mesylate
INJECTABLE;INJECTION078718-002Sep 15, 2009APRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: deferoxamine mesylate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis
DESFERAL
deferoxamine mesylate
INJECTABLE;INJECTION016267-001Approved Prior to Jan 1, 19823,471,476► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
US Army
QuintilesIMS
Harvard Business School
Healthtrust
US Department of Justice
Dow
Federal Trade Commission
Julphar
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot